Literature DB >> 26758434

A premature proposal for new liver cancer seromarkers.

Liu-Cheng Wu1, Wen-Feng Gong2, Jian-Hong Zhong3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26758434     DOI： 10.1007/s13277-016-4801-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  16 in total

1.  Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Fei-Xiang Wu; Hang Li
Journal:  Tumour Biol       Date:  2014-09-09

2.  Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.

Authors:  Surachate Siripongsakun; Sindy H Wei; Stephanie Lin; Jeffrey Chen; Steven S Raman; James Sayre; Myron J Tong; David S Lu
Journal:  J Gastroenterol Hepatol       Date:  2014-01       Impact factor: 4.029

3.  Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.

Authors:  Changzai Li; Zhiming Zhang; Pan Zhang; Jianyong Liu
Journal:  Hepatol Res       Date:  2013-08-19       Impact factor: 4.288

4.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

5.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

6.  Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Authors:  Jian-hong Zhong; Yang Ke; Wen-feng Gong; Bang-de Xiang; Liang Ma; Xin-ping Ye; Tao Peng; Gui-sheng Xie; Le-qun Li
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

7.  Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.

Authors:  Yunsheng Zhao; Meng Wang; Chenying Cui; Lina Zhang; Fei Liao; Hongchen Li; Xia Wu
Journal:  Cancer Biomark       Date:  2015       Impact factor: 4.388

8.  Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?

Authors:  Atsushi Kudo; Satoshi Matsumura; Daisuke Ban; Takumi Irie; Takanori Ochiai; Shinji Tanaka; Shigeki Arii; Minoru Tanabe
Journal:  Hepatol Res       Date:  2014-05-06       Impact factor: 4.288

Review 9.  Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.

Authors:  Ying Zhou; Xin Yin; Jun Ying; Boheng Zhang
Journal:  BMC Cancer       Date:  2012-01-16       Impact factor: 4.430

10.  Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma.

Authors:  Jian-Hong Zhong; Xue-Mei You; Shi-Dong Lu; Yan-Yan Wang; Bang-De Xiang; Liang Ma; Fei-Xiang Wu; Wei-Ping Yuan; Ying Chen; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.